ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Abivax S.A.
114.90
-0.0500
-0.04%
成交量:
77.23萬
成交額:
8,855.04萬
市值:
100.03億
市盈率:
-22.03
高:
115.92
開:
114.00
低:
113.30
收:
114.95
52周最高:
148.83
52周最低:
69.81
股本:
8,705.45萬
流通股本:
7,645.54萬
量比:
1.38
換手率:
1.01%
股息:
- -
股息率:
- -
每股收益(TTM):
-5.2168
每股收益(LYR):
-5.6758
淨資產收益率:
-157.07%
總資產收益率:
-44.65%
市淨率:
19.97
市盈率(LYR):
-20.24
資料載入中...
總覽
公司
新聞資訊
公告
異動解讀|Abivax盤中上漲5.18%,摩根士丹利大幅上調目標價至180美元
行情直击
·
07/30
Abivax(ABVX)宣佈完成9.2 億美元美股存託憑證增發
金吾财讯
·
07/07
異動解讀|Abivax S.A.盤前上漲6.46%,9.2億美元增發正式交割提振持續做多情緒
行情直击
·
07/06
異動解讀|Abivax S.A.夜盤上漲5.74%,9.2億美元增發正式交割提振持續做多情緒
行情直击
·
07/06
異動解讀|Abivax S.A.盤中上漲5.39%,承銷商全額行使超額配售權總募資擴至9.2億美元
行情直击
·
07/02
異動解讀|Abivax S.A.盤前上漲6.27%,8億美元增發定價完成後市場追捧延續
行情直击
·
07/02
異動解讀|Abivax S.A.夜盤上漲6.37%,8億美元增發定價完成後市場追捧延續
行情直击
·
07/02
美股異動 | 潰瘍性結腸炎療法obefazimod取得積極數據 Abivax S.A.(ABVX.US)暴升逾40%
智通财经
·
06/30
異動解讀|Abivax S.A.盤中上漲36.68%,三期維持試驗補充數據積極消除安全性爭議
行情直击
·
06/30
法國生物科技公司Abivax盤前飆升35%,實驗性藥物最新數據提振市場信心
老虎资讯综合
·
06/30
焦點股追蹤:Strategy、超微電腦、星座品牌
投资观察
·
06/30
異動解讀|Abivax S.A.盤前上漲25.85%,三期維持試驗補充數據積極驅動股價加速反彈
行情直击
·
06/30
異動解讀|Abivax S.A.夜盤上漲27.93%,三期維持試驗補充數據積極加速股價反彈
行情直击
·
06/30
異動解讀|Abivax S.A.盤後上漲21.37%,三期試驗安全性爭議持續消化中反彈動能加強
行情直击
·
06/30
異動解讀|Abivax S.A.盤中上漲5.48%,三期試驗安全性爭議中多空博弈加劇
行情直击
·
06/26
異動解讀|Abivax S.A.盤後下跌5.38%,三期試驗安全性爭議持續壓制反彈動能
行情直击
·
06/26
異動解讀|Abivax S.A.盤中下跌5.62%,三期試驗安全性爭議持續壓制反彈動能
行情直击
·
06/26
異動解讀|Abivax S.A.夜盤下跌5.84%,三期試驗安全性爭議持續壓制股價反彈
行情直击
·
06/25
異動解讀|Abivax S.A.盤中下跌5.15%,三期試驗安全性爭議未消致反彈行情受阻
行情直击
·
06/24
異動解讀|Abivax S.A.盤中上漲5.15%,三期試驗安全性爭議消化後股價延續技術性反彈
行情直击
·
06/17
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/ABVX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVX\",,,,,undefined,":{"symbol":"ABVX","market":"US","secType":"STK","nameCN":"Abivax S.A.","latestPrice":114.9,"timestamp":1787593849181,"preClose":114.95,"halted":0,"volume":772343,"delay":0,"changeRate":-0.0004349717268377308,"floatShares":76455400,"shares":87054500,"eps":-5.216782,"marketStatus":"交易中","change":-0.05,"latestTime":"08-24 13:50:50 EDT","open":114,"high":115.92,"low":113.3,"amount":88550368.42223,"amplitude":0.022793,"askPrice":114.91,"askSize":10,"bidPrice":114.85,"bidSize":108,"shortable":3,"etf":0,"ttmEps":-5.216782,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1697774400000,"exchange":"NASDAQ","adjPreClose":114.95,"preHourTrading":{"tag":"盘前","latestPrice":113.95,"preClose":114.95,"latestTime":"09:29 EDT","volume":23208,"amount":2648739.94776,"timestamp":1787578197035,"change":-1,"changeRate":-0.008699,"amplitude":0.02314},"postHourTrading":{"tag":"盘后","latestPrice":115.7,"preClose":114.95,"latestTime":"19:59 EDT","volume":14335,"amount":1657748.9935,"timestamp":1787356788071,"change":0.75,"changeRate":0.006525,"amplitude":0.010874},"volumeRatio":1.375208,"impliedVol":0.6791,"impliedVolPercentile":0.1288},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVX\",,,,,undefined,":{"symbol":"ABVX","floatShares":76455400,"roa":"-44.65%","roe":"-157.07%","lyrEps":-5.675825,"volumeRatio":1.375208,"shares":87054500,"dividePrice":0,"high":115.92,"amplitude":0.022793,"preClose":114.95,"low":113.3,"week52Low":69.81,"pbRate":"19.97","psRate":"1743.76","week52High":148.83,"institutionHeld":0,"latestPrice":114.9,"committee":0.830508,"eps":-5.216782,"divideRate":0,"volume":772343,"delay":0,"ttmEps":-5.216782,"open":114,"prevYearClose":134.855,"prevWeekClose":114.95,"prevMonthClose":124.92,"prevQuarterClose":133.26,"fiveDayClose":120.73,"twentyDayClose":128,"sixtyDayClose":129.5,"earningDate":1789920000000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABVX\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"ABVX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1790020800000,"name":null,"time":"盤後","dateTimestamp":1789963200000,"actualEps":null},{"market":"US","date":"2026-05-22","symbol":"ABVX","fiscalQuarterEnding":"2026/03","expectedEps":-1.07,"name":null,"time":"盤後","type":"earning","dateTimestamp":1779422400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-03-23","symbol":"ABVX","fiscalQuarterEnding":"2025/12","expectedEps":-1.7,"name":null,"time":"盤後","type":"earning","dateTimestamp":1774238400000,"reportTimeType":"post","actualEps":-1.19},{"market":"US","date":"2025-12-15","symbol":"ABVX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1765774800000,"reportTimeType":"post","actualEps":-2.45},{"market":"US","date":"2025-09-08","symbol":"ABVX","fiscalQuarterEnding":"2025/06","expectedEps":-0.9,"name":null,"time":"盤後","type":"earning","dateTimestamp":1757304000000,"reportTimeType":"post","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABVX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.5,"hold":0.0833,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":12,"updateTime":1784001600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABVX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABVX","date":"2026-08-21","current":-22.025072,"percent":0.145985,"low":-44.789917,"twenty":-27.205522,"median":-6.763653,"eighty":-2.62524,"high":-0.02231,"avg":-13.734597,"sd":11.990294,"marketCap":10949286420.23},"quantilePoints":[{"date":"2023-10-27","current":-7.823172,"twenty":-7.328793,"median":-6.587224,"eighty":-5.845656,"marketCap":753894810.45},{"date":"2023-11-03","current":-6.291292,"twenty":-6.250217,"median":-6.06538,"eighty":-6.010614,"marketCap":611163613.59},{"date":"2023-11-10","current":-6.503512,"twenty":-6.645905,"median":-6.346058,"eighty":-6.06538,"marketCap":637532258.17},{"date":"2023-11-17","current":-7.092251,"twenty":-6.941614,"median":-6.503512,"eighty":-6.069488,"marketCap":704987904.63},{"date":"2023-11-24","current":-6.558278,"twenty":-6.982681,"median":-6.613045,"eighty":-6.085918,"marketCap":654468961.83},{"date":"2023-12-01","current":-6.469283,"twenty":-6.777344,"median":-6.486397,"eighty":-6.085918,"marketCap":645658268.08},{"date":"2023-12-08","current":-6.667811,"twenty":-6.729423,"median":-6.558278,"eighty":-6.270755,"marketCap":658292574.17},{"date":"2023-12-15","current":-6.708886,"twenty":-6.708886,"median":-6.565124,"eighty":-6.291292,"marketCap":675019398.57},{"date":"2023-12-22","current":-6.859493,"twenty":-6.749961,"median":-6.585661,"eighty":-6.304984,"marketCap":690021158.62},{"date":"2023-12-29","current":-6.722577,"twenty":-6.78282,"median":-6.609622,"eighty":-6.321414,"marketCap":681416772.26},{"date":"2024-01-05","current":-6.626736,"twenty":-6.777344,"median":-6.626736,"eighty":-6.346059,"marketCap":664561787.4},{"date":"2024-01-12","current":-6.845802,"twenty":-6.796512,"median":-6.667811,"eighty":-6.407671,"marketCap":685854313.55},{"date":"2024-01-19","current":-7.023793,"twenty":-6.859493,"median":-6.681503,"eighty":-6.435054,"marketCap":698334715.34},{"date":"2024-01-26","current":-7.986412,"twenty":-6.982718,"median":-6.681503,"eighty":-6.435054,"marketCap":792063074.67},{"date":"2024-02-02","current":-8.137618,"twenty":-7.092251,"median":-6.715732,"eighty":-6.469283,"marketCap":807847078.54},{"date":"2024-02-09","current":-7.972666,"twenty":-7.379774,"median":-6.743115,"eighty":-6.503512,"marketCap":785337680.3},{"date":"2024-02-16","current":-7.738985,"twenty":-7.738985,"median":-6.763653,"eighty":-6.503512,"marketCap":761909093.06},{"date":"2024-02-23","current":-8.385046,"twenty":-7.788813,"median":-6.78419,"eighty":-6.508989,"marketCap":829978945.38},{"date":"2024-03-01","current":-8.879901,"twenty":-7.848771,"median":-6.818419,"eighty":-6.548694,"marketCap":878391233.38},{"date":"2024-03-08","current":-8.921139,"twenty":-7.986412,"median":-6.859493,"eighty":-6.569232,"marketCap":892211380.33},{"date":"2024-03-15","current":-8.659965,"twenty":-8.228342,"median":-6.982681,"eighty":-6.577447,"marketCap":863166780.31},{"date":"2024-03-22","current":-9.319772,"twenty":-8.319065,"median":-7.010102,"eighty":-6.584292,"marketCap":926107447.06},{"date":"2024-03-28","current":-9.209804,"twenty":-8.585737,"median":-7.078559,"eighty":-6.597984,"marketCap":910336135.23},{"date":"2024-04-05","current":-9.732151,"twenty":-8.736943,"median":-7.311316,"eighty":-6.610307,"marketCap":967400801.65},{"date":"2024-04-12","current":-5.879845,"twenty":-8.706701,"median":-7.078559,"eighty":-6.566493,"marketCap":928230894.29},{"date":"2024-04-19","current":-6.030284,"twenty":-8.692955,"median":-6.99641,"eighty":-6.48982,"marketCap":950004364.47},{"date":"2024-04-26","current":-6.311356,"twenty":-8.670962,"median":-6.941624,"eighty":-6.433272,"marketCap":998864220.67},{"date":"2024-05-03","current":-5.987697,"twenty":-8.585737,"median":-6.859493,"eighty":-6.311356,"marketCap":946423801.22},{"date":"2024-05-10","current":-5.698107,"twenty":-8.470271,"median":-6.80815,"eighty":-6.289097,"marketCap":907055615.77},{"date":"2024-05-17","current":-5.502208,"twenty":-8.401541,"median":-6.777344,"eighty":-6.21545,"marketCap":883582818.48},{"date":"2024-05-24","current":-5.348896,"twenty":-8.33556,"median":-6.749961,"eighty":-6.06538,"marketCap":855336978.03},{"date":"2024-05-31","current":-5.357413,"twenty":-8.297072,"median":-6.736269,"eighty":-6.030284,"marketCap":858278233.57},{"date":"2024-06-07","current":-5.493691,"twenty":-8.288824,"median":-6.708886,"eighty":-5.988933,"marketCap":883175015.23},{"date":"2024-06-14","current":-5.042271,"twenty":-8.277827,"median":-6.681503,"eighty":-5.938296,"marketCap":801878490.85},{"date":"2024-06-21","current":-5.510725,"twenty":-8.253084,"median":-6.681503,"eighty":-5.777439,"marketCap":872433075.44},{"date":"2024-06-28","current":-4.974132,"twenty":-8.244837,"median":-6.681503,"eighty":-5.74004,"marketCap":786723361.52},{"date":"2024-07-05","current":-5.306309,"twenty":-8.203599,"median":-6.667811,"eighty":-5.629968,"marketCap":847517911.35},{"date":"2024-07-12","current":-5.408517,"twenty":-8.118374,"median":-6.619891,"eighty":-5.595899,"marketCap":868631706.71},{"date":"2024-07-15","current":-5.417034,"twenty":-8.099129,"median":-6.613045,"eighty":-5.590788,"marketCap":873513053.92},{"date":"2024-08-02","current":-4.676203,"twenty":-8.079885,"median":-6.609622,"eighty":-5.583974,"marketCap":745105907.03},{"date":"2024-08-09","current":-4.513478,"twenty":-8.008406,"median":-6.578816,"eighty":-5.515836,"marketCap":727494223.22},{"date":"2024-08-16","current":-4.316495,"twenty":-7.986412,"median":-6.534318,"eighty":-5.490284,"marketCap":700482151.8},{"date":"2024-08-23","current":-4.453526,"twenty":-7.978164,"median":-6.503512,"eighty":-5.44429,"marketCap":730827498.61},{"date":"2024-08-30","current":-4.898879,"twenty":-7.906686,"median":-6.449861,"eighty":-5.413627,"marketCap":801684090.61},{"date":"2024-09-06","current":-4.667638,"twenty":-7.862699,"median":-6.432827,"eighty":-5.36082,"marketCap":764519824.83},{"date":"2024-09-13","current":-3.822511,"twenty":-7.855735,"median":-6.332367,"eighty":-5.335268,"marketCap":748409890.75},{"date":"2024-09-20","current":-3.623827,"twenty":-7.841256,"median":-6.30817,"eighty":-5.285867,"marketCap":716147844.73},{"date":"2024-09-27","current":-3.630961,"twenty":-7.835207,"median":-6.291292,"eighty":-5.156403,"marketCap":720043812.45},{"date":"2024-10-04","current":-3.210083,"twenty":-7.830393,"median":-6.281546,"eighty":-4.898879,"marketCap":627325694.46},{"date":"2024-10-11","current":-2.96041,"twenty":-7.805992,"median":-6.132492,"eighty":-4.671064,"marketCap":573856377.14},{"date":"2024-10-18","current":-3.434789,"twenty":-7.774725,"median":-6.075649,"eighty":-4.6094,"marketCap":659899758.53},{"date":"2024-10-25","current":-3.324219,"twenty":-7.75548,"median":-6.033455,"eighty":-4.49121,"marketCap":637070240.87},{"date":"2024-10-31","current":-3.438356,"twenty":-7.738985,"median":-6.030284,"eighty":-4.463804,"marketCap":662378132.46},{"date":"2024-11-08","current":-3.427655,"twenty":-7.738985,"median":-5.993854,"eighty":-4.429546,"marketCap":655972131.38},{"date":"2024-11-15","current":-3.106647,"twenty":-7.711493,"median":-5.970662,"eighty":-4.328485,"marketCap":583153684.93},{"date":"2024-11-22","current":-3.010345,"twenty":-7.590528,"median":-5.940851,"eighty":-3.765459,"marketCap":560275247.04},{"date":"2024-11-29","current":-2.837956,"twenty":-7.546541,"median":-5.882667,"eighty":-3.688029,"marketCap":531199944.09},{"date":"2024-12-06","current":-2.848666,"twenty":-7.379774,"median":-5.732176,"eighty":-3.623827,"marketCap":534218918.72},{"date":"2024-12-13","current":-2.548806,"twenty":-7.311316,"median":-5.65552,"eighty":-3.566759,"marketCap":474325506.61},{"date":"2024-12-20","current":-2.520248,"twenty":-7.311316,"median":-5.604416,"eighty":-3.452623,"marketCap":464239022.01},{"date":"2024-12-27","current":-2.516678,"twenty":-7.267503,"median":-5.595899,"eighty":-3.437643,"marketCap":465029850.03},{"date":"2025-01-03","current":-2.49883,"twenty":-7.157971,"median":-5.578864,"eighty":-3.421948,"marketCap":454676281.41},{"date":"2025-01-10","current":-2.309632,"twenty":-7.081298,"median":-5.52776,"eighty":-3.400548,"marketCap":421851498.87},{"date":"2025-01-17","current":-2.156736,"twenty":-7.048438,"median":-5.506467,"eighty":-3.355607,"marketCap":393925230.6},{"date":"2025-01-24","current":-2.178161,"twenty":-7.018316,"median":-5.493691,"eighty":-3.318513,"marketCap":402353167.1},{"date":"2025-01-31","current":-2.156736,"twenty":-6.993672,"median":-5.459621,"eighty":-3.135894,"marketCap":398893952.88},{"date":"2025-02-07","current":-2.038902,"twenty":-6.982711,"median":-5.442586,"eighty":-3.053859,"marketCap":375339390.95},{"date":"2025-02-14","current":-2.431685,"twenty":-6.966258,"median":-5.417034,"eighty":-3.014625,"marketCap":450591803.66},{"date":"2025-02-21","current":-2.725249,"twenty":-6.900568,"median":-5.408517,"eighty":-2.924742,"marketCap":505993414.61},{"date":"2025-02-28","current":-2.478798,"twenty":-6.859493,"median":-5.361671,"eighty":-2.877224,"marketCap":457649034.34},{"date":"2025-03-07","current":-2.62524,"twenty":-6.859493,"median":-5.348896,"eighty":-2.848666,"marketCap":504421902.75},{"date":"2025-03-14","current":-1.950178,"twenty":-6.845802,"median":-5.331861,"eighty":-2.792772,"marketCap":375893933.73},{"date":"2025-03-21","current":-2.425222,"twenty":-6.818419,"median":-5.306309,"eighty":-2.725249,"marketCap":466899893.66},{"date":"2025-03-28","current":-2.16502,"twenty":-6.797881,"median":-5.23817,"eighty":-2.643099,"marketCap":411881933.29},{"date":"2025-04-04","current":-1.798189,"twenty":-6.791035,"median":-5.118927,"eighty":-2.598783,"marketCap":350804145.45},{"date":"2025-04-11","current":-1.7874,"twenty":-6.777344,"median":-4.936505,"eighty":-2.541667,"marketCap":352326323.68},{"date":"2025-04-17","current":-1.884502,"twenty":-6.777344,"median":-4.813235,"eighty":-2.527388,"marketCap":377676205.37},{"date":"2025-04-25","current":-2.187427,"twenty":-6.755438,"median":-4.676203,"eighty":-2.49883,"marketCap":437738722.61},{"date":"2025-05-02","current":-2.334934,"twenty":-6.749961,"median":-4.641945,"eighty":-2.473083,"marketCap":464043181.1},{"date":"2025-05-09","current":-2.219807,"twenty":-6.744484,"median":-4.599123,"eighty":-2.430392,"marketCap":441113036.42},{"date":"2025-05-16","current":-1.936126,"twenty":-6.732161,"median":-4.504914,"eighty":-2.406016,"marketCap":381685399.33},{"date":"2025-05-23","current":-1.820966,"twenty":-6.723946,"median":-4.470655,"eighty":-2.350016,"marketCap":362101694.69},{"date":"2025-05-30","current":-1.900139,"twenty":-6.714362,"median":-4.462091,"eighty":-2.329767,"marketCap":380507035.56},{"date":"2025-06-06","current":-2.513168,"twenty":-6.708886,"median":-4.444961,"eighty":-2.329767,"marketCap":534533766.17},{"date":"2025-06-13","current":-1.97798,"twenty":-6.692456,"median":-4.410704,"eighty":-2.276706,"marketCap":425231303.24},{"date":"2025-06-20","current":-1.793505,"twenty":-6.681503,"median":-4.342188,"eighty":-2.264946,"marketCap":382035064.22},{"date":"2025-06-27","current":-2.138541,"twenty":-6.681503,"median":-4.299366,"eighty":-2.248589,"marketCap":464697383.01},{"date":"2025-07-03","current":-2.289493,"twenty":-6.681503,"median":-3.786854,"eighty":-2.248786,"marketCap":500190485.77},{"date":"2025-07-11","current":-2.429597,"twenty":-6.678765,"median":-3.702296,"eighty":-2.250599,"marketCap":527449091.87},{"date":"2025-07-18","current":-2.945587,"twenty":-6.667811,"median":-3.641661,"eighty":-2.25491,"marketCap":634057320.66},{"date":"2025-07-25","current":-23.061864,"twenty":-6.681503,"median":-3.652361,"eighty":-2.257399,"marketCap":5041932651.84},{"date":"2025-08-01","current":-24.891124,"twenty":-6.708886,"median":-3.72013,"eighty":-2.264403,"marketCap":5288723102.26},{"date":"2025-08-08","current":-24.565749,"twenty":-6.748592,"median":-3.822511,"eighty":-2.266806,"marketCap":5307007573.85},{"date":"2025-08-15","current":-24.412019,"twenty":-6.788297,"median":-4.320777,"eighty":-2.26785,"marketCap":5283013491.79},{"date":"2025-08-22","current":-27.056654,"twenty":-6.856755,"median":-4.350753,"eighty":-2.269596,"marketCap":5836300408.78},{"date":"2025-08-29","current":-27.951762,"twenty":-6.982711,"median":-4.432115,"eighty":-2.275271,"marketCap":6054693876.38},{"date":"2025-09-05","current":-31.125324,"twenty":-7.064868,"median":-4.453526,"eighty":-2.278142,"marketCap":6729569738.1},{"date":"2025-09-12","current":-27.34583,"twenty":-7.311316,"median":-4.470655,"eighty":-2.289493,"marketCap":6274864374.63},{"date":"2025-09-19","current":-27.152436,"twenty":-7.738985,"median":-4.492066,"eighty":-2.306579,"marketCap":6253253490.1},{"date":"2025-09-26","current":-27.191115,"twenty":-7.780223,"median":-4.581994,"eighty":-2.309632,"marketCap":6202939418.56},{"date":"2025-10-03","current":-27.92601,"twenty":-7.845289,"median":-4.624816,"eighty":-2.312121,"marketCap":6384002898.09},{"date":"2025-10-10","current":-30.594839,"twenty":-7.986412,"median":-4.667638,"eighty":-2.323665,"marketCap":6912424239.13},{"date":"2025-10-17","current":-30.362767,"twenty":-8.220094,"median":-4.710461,"eighty":-2.327411,"marketCap":6924043391.69},{"date":"2025-10-24","current":-30.633518,"twenty":-8.30257,"median":-4.898879,"eighty":-2.331337,"marketCap":6947674791.64},{"date":"2025-10-31","current":-35.158924,"twenty":-8.659965,"median":-5.080599,"eighty":-2.331337,"marketCap":7943607628.35},{"date":"2025-11-07","current":-34.191957,"twenty":-8.769933,"median":-5.221135,"eighty":-2.334934,"marketCap":7707312075.45},{"date":"2025-11-14","current":-36.435321,"twenty":-8.934885,"median":-5.289274,"eighty":-2.340751,"marketCap":8287572122.24},{"date":"2025-11-21","current":-39.68433,"twenty":-9.168566,"median":-5.331861,"eighty":-2.344168,"marketCap":8947428940.69},{"date":"2025-11-28","current":-41.772979,"twenty":-9.226299,"median":-5.340378,"eighty":-2.351863,"marketCap":9466410187.89},{"date":"2025-12-05","current":-36.473999,"twenty":-9.286782,"median":-5.354345,"eighty":-2.35938,"marketCap":8310882570.26},{"date":"2025-12-12","current":-41.850337,"twenty":-9.520464,"median":-5.382965,"eighty":-2.371798,"marketCap":9611017354.25},{"date":"2025-12-19","current":-26.516104,"twenty":-20.549981,"median":-5.417034,"eighty":-2.383656,"marketCap":9139275129.17},{"date":"2025-12-26","current":-32.349646,"twenty":-23.956328,"median":-5.429811,"eighty":-2.389415,"marketCap":11186696717.72},{"date":"2026-01-02","current":-30.493519,"twenty":-24.259916,"median":-5.455362,"eighty":-2.392505,"marketCap":10512635312.43},{"date":"2026-01-09","current":-26.250942,"twenty":-24.408436,"median":-5.485173,"eighty":-2.400028,"marketCap":8979345802.35},{"date":"2026-01-16","current":-27.099458,"twenty":-24.671496,"median":-5.49795,"eighty":-2.410756,"marketCap":9234075745.3},{"date":"2026-01-23","current":-28.266166,"twenty":-24.923661,"median":-5.514984,"eighty":-2.41264,"marketCap":9748190743.74},{"date":"2026-01-30","current":-25.137266,"twenty":-25.338253,"median":-5.570347,"eighty":-2.413186,"marketCap":8803591875.67},{"date":"2026-02-06","current":-25.694104,"twenty":-25.420854,"median":-5.59164,"eighty":-2.415525,"marketCap":8892505001.77},{"date":"2026-02-13","current":-28.160102,"twenty":-25.842594,"median":-5.604416,"eighty":-2.424554,"marketCap":9808417129.46},{"date":"2026-02-20","current":-29.8041,"twenty":-26.038814,"median":-5.612933,"eighty":-2.425222,"marketCap":10293092752.09},{"date":"2026-02-27","current":-27.205522,"twenty":-26.533578,"median":-5.732176,"eighty":-2.429597,"marketCap":9418925305.5},{"date":"2026-03-06","current":-24.925137,"twenty":-26.516104,"median":-5.879845,"eighty":-2.431685,"marketCap":8459789891.3},{"date":"2026-03-13","current":-26.834297,"twenty":-26.533578,"median":-5.940851,"eighty":-2.439509,"marketCap":9079426835.73},{"date":"2026-03-20","current":-29.008617,"twenty":-26.834297,"median":-5.970662,"eighty":-2.463662,"marketCap":9819639406.07},{"date":"2026-03-27","current":-21.015395,"twenty":-26.834297,"median":-5.993854,"eighty":-2.464511,"marketCap":8146846911.19},{"date":"2026-04-02","current":-23.889698,"twenty":-26.791871,"median":-6.021767,"eighty":-2.473083,"marketCap":9269655072.73},{"date":"2026-04-10","current":-25.421089,"twenty":-26.781265,"median":-6.033455,"eighty":-2.478084,"marketCap":9995412686.01},{"date":"2026-04-17","current":-24.667173,"twenty":-26.643534,"median":-6.075649,"eighty":-2.488644,"marketCap":9762937178.52},{"date":"2026-04-24","current":-22.617465,"twenty":-26.548683,"median":-6.132492,"eighty":-2.497285,"marketCap":8904504345.79},{"date":"2026-05-01","current":-22.723485,"twenty":-26.519599,"median":-6.281546,"eighty":-2.49883,"marketCap":8959888176.91},{"date":"2026-05-08","current":-24.855652,"twenty":-26.431252,"median":-6.291292,"eighty":-2.49883,"marketCap":9832902989.64},{"date":"2026-05-15","current":-23.336041,"twenty":-26.388826,"median":-6.30817,"eighty":-2.5103,"marketCap":9155235319.25},{"date":"2026-05-22","current":-25.110387,"twenty":-26.341097,"median":-6.332367,"eighty":-2.515976,"marketCap":9778300609.43},{"date":"2026-05-29","current":-27.204576,"twenty":-26.452465,"median":-6.430599,"eighty":-2.51882,"marketCap":10531826440.97},{"date":"2026-06-05","current":-21.07515,"twenty":-26.452465,"median":-6.449861,"eighty":-2.524532,"marketCap":8138996627.53},{"date":"2026-06-12","current":-20.403432,"twenty":-26.394129,"median":-6.503512,"eighty":-2.527388,"marketCap":7810578705.92},{"date":"2026-06-18","current":-20.679316,"twenty":-26.366489,"median":-6.510358,"eighty":-2.527388,"marketCap":7884389896.71},{"date":"2026-06-26","current":-20.271488,"twenty":-26.33676,"median":-6.575393,"eighty":-2.530811,"marketCap":7666425554.42},{"date":"2026-07-02","current":-30.659126,"twenty":-26.404736,"median":-6.59593,"eighty":-2.53709,"marketCap":11655941374.46},{"date":"2026-07-10","current":-31.890615,"twenty":-26.746832,"median":-6.626736,"eighty":-2.543095,"marketCap":12110267741.2},{"date":"2026-07-17","current":-30.930523,"twenty":-26.834297,"median":-6.667811,"eighty":-2.55052,"marketCap":11755084937.65},{"date":"2026-07-24","current":-29.269824,"twenty":-26.959814,"median":-6.681503,"eighty":-2.564944,"marketCap":11055640094.37},{"date":"2026-07-31","current":-27.583176,"twenty":-27.075079,"median":-6.681503,"eighty":-2.595213,"marketCap":10549310515.77},{"date":"2026-08-07","current":-29.607153,"twenty":-27.191115,"median":-6.715732,"eighty":-2.598783,"marketCap":11333828453.56},{"date":"2026-08-14","current":-26.649033,"twenty":-27.205522,"median":-6.743115,"eighty":-2.618096,"marketCap":10213208013.38},{"date":"2026-08-21","current":-28.220286,"twenty":-27.205522,"median":-6.763653,"eighty":-2.62524,"marketCap":10949286420.23}],"updateTime":1787593850800},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABVX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1100782164","title":"異動解讀|Abivax盤中上漲5.18%,摩根士丹利大幅上調目標價至180美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100782164","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100782164?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 23:00","pubTimestamp":1785423618,"startTime":"0","endTime":"0","summary":"7月30日,Abivax盘中上涨5.18%,报124.295美元/股,成交额5488.63万美元。消息面上,摩根士丹利近日发布研报,将Abivax目标价从132美元大幅上调至180美元,维持\"增持\"评级。此外,此前市场对标签限制及监管风险的担忧已随临床数据改善而缓解。公司7月初完成约9.2亿美元ADS发行,资金可支撑运营至2029年第四季度,为obefazimod美国商业化提供充足弹药。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649899419","title":"Abivax(ABVX)宣佈完成9.2 億美元美股存託憑證增發","url":"https://stock-news.laohu8.com/highlight/detail?id=2649899419","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649899419?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 18:08","pubTimestamp":1783418915,"startTime":"0","endTime":"0","summary":"金吾财讯 | 法美临床阶段生物药企 Abivax 公告美国存托凭证承销公开发行正式完成,承销商全额行使超额配售权,本次发行合计募资总额9.2 亿美元,扣除承销佣金与发行费用后净募资约 8.741 亿美元,大幅拉长公司研发现金跑道。本次共计发行 736 万份 ADS,每份对应公司 1 股普通股,全部由 Abivax 自身发售。公司股票两地双重上市,普通股在巴黎泛欧交易所挂牌,ADS 于纳斯达克全球市场交易。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/OGE4NjMzOTE0MzMzMjk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/OGE4NjMzOTE0MzMzMjk=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302263","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114490786","title":"異動解讀|Abivax S.A.盤前上漲6.46%,9.2億美元增發正式交割提振持續做多情緒","url":"https://stock-news.laohu8.com/highlight/detail?id=1114490786","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114490786?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 16:06","pubTimestamp":1783325216,"startTime":"0","endTime":"0","summary":"7月6日,Abivax S.A.盘前上涨6.46%,报152.5美元/股,成交额58.0万美元。消息面上,公司此前宣布承销商全额行使超额配售权,额外购入96万股ADS,总募资规模从8亿美元扩大至约9.2亿美元,净募集资金约8.74亿美元,该发行于本周一正式完成交割。此前公司公布ABTECT维持试验Part 2积极数据消除安全性争议,叠加发行规模由最初6亿美元两度上调并获超额配售全额认购,机构需求旺盛持续强化市场信心,股价维持在125美元发行价上方运行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165938491","title":"異動解讀|Abivax S.A.夜盤上漲5.74%,9.2億美元增發正式交割提振持續做多情緒","url":"https://stock-news.laohu8.com/highlight/detail?id=1165938491","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165938491?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 15:01","pubTimestamp":1783321284,"startTime":"0","endTime":"0","summary":"7月6日,Abivax S.A.夜盘上涨5.74%,报152.96美元/股,成交额100.17万美元。消息面上,公司此前宣布承销商全额行使超额配售权,额外购入96万股ADS,总募资规模从8亿美元扩大至约9.2亿美元,净募集资金约8.74亿美元,该发行于本周一正式完成交割。此前公司公布ABTECT维持试验Part 2积极数据,消除安全性争议后股价已大幅反弹,叠加发行规模由最初6亿美元两度上调并获超额配售全额认购,机构需求旺盛持续强化市场信心,股价维持在125美元发行价上方运行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189220198","title":"異動解讀|Abivax S.A.盤中上漲5.39%,承銷商全額行使超額配售權總募資擴至9.2億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189220198","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189220198?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 21:36","pubTimestamp":1782999412,"startTime":"0","endTime":"0","summary":"7月2日,Abivax S.A.盘中上涨5.39%,报140.67美元/股,成交额6686.63万美元。消息面上,公司宣布其ADS公开发行的承销商已全额行使超额配售权,额外购买96万股ADS,总募集金额从8亿美元提升至约9.2亿美元,预计下周一完成交割。此前公司公布ABTECT维持试验积极数据消除安全性争议,股价已大幅反弹,当前股价持续高于每股125美元的发行价运行,超额配售全额行使进一步强化市场信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123159008","title":"異動解讀|Abivax S.A.盤前上漲6.27%,8億美元增發定價完成後市場追捧延續","url":"https://stock-news.laohu8.com/highlight/detail?id=1123159008","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123159008?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 16:05","pubTimestamp":1782979503,"startTime":"0","endTime":"0","summary":"7月2日,Abivax S.A.盘前上涨6.27%,报140.88美元/股,成交额42.52万美元。消息面上,公司完成8亿美元ADS公开发行定价,以每股125美元发行640万股美国存托凭证,发行规模从此前的6亿美元上调至8亿美元,显示机构认购需求旺盛。募集资金将主要用于核心药物obefazimod在美国的商业化推进及溃疡性结肠炎和克罗恩病的临床研发。此前公司公布ABTECT维持试验积极数据消除安全性争议,股价已大幅反弹超38%,本次增发超额扩容进一步确认市场信心,当前股价持续高于发行价运行。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140015042","title":"異動解讀|Abivax S.A.夜盤上漲6.37%,8億美元增發定價完成後市場追捧延續","url":"https://stock-news.laohu8.com/highlight/detail?id=1140015042","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140015042?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 15:05","pubTimestamp":1782975924,"startTime":"0","endTime":"0","summary":"7月2日,Abivax S.A.夜盘上涨6.37%,报141.0美元/股,成交额41.41万美元。消息面上,公司完成8亿美元ADS公开发行定价,以每股125美元发行640万股美国存托凭证,发行规模从此前的6亿美元上调至8亿美元,显示机构认购需求旺盛。募集资金将主要用于核心药物obefazimod在美国的商业化推进及溃疡性结肠炎和克罗恩病的临床研发。此前公司公布ABTECT维持试验积极数据消除安全性争议,股价已大幅反弹超38%,本次增发超额扩容进一步确认市场信心,当前股价持续高于发行价运行。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647557096","title":"美股異動 | 潰瘍性結腸炎療法obefazimod取得積極數據 Abivax S.A.(ABVX.US)暴升逾40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647557096","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647557096?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 23:06","pubTimestamp":1782831981,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150042476","title":"異動解讀|Abivax S.A.盤中上漲36.68%,三期維持試驗補充數據積極消除安全性爭議","url":"https://stock-news.laohu8.com/highlight/detail?id=1150042476","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150042476?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 21:31","pubTimestamp":1782826310,"startTime":"0","endTime":"0","summary":"6月30日,Abivax S.A.盘中上涨36.68%,报131.53美元/股,成交额1.81亿美元。此前50mg组曾因报告多例癌症病例致股价从130美元附近暴跌至约70美元,本次数据消除安全性新增隐患,前期争议逐步消化,多头情绪加速升温。此外,Wedbush将目标价从90美元上调至110美元。公司表示仍计划于第四季度向FDA提交新药上市申请。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178186665","title":"法國生物科技公司Abivax盤前飆升35%,實驗性藥物最新數據提振市場信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1178186665","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178186665?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 19:29","pubTimestamp":1782818945,"startTime":"0","endTime":"0","summary":"要点法国生物科技公司 Abivax 公布,其实验性药物 obefazimod 的最新数据显示,恶性肿瘤发生率与预期背景发生率一致,推动公司股价周二盘前大幅上涨。法国生物科技公司 Abivax 周二股价大涨,此前公司公布了其治疗炎症性肠病核心候选药物的最新数据。Abivax 股价盘前上涨35%。Abivax 表示,公司仍计划于2026年第四季度向美国食品药品监督管理局提交 obefazimod 的新药上市申请。","market":"us","thumbnail":"https://static.tigerbbs.com/3c6daacf13f78492ec38a4e178ddca49","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3c6daacf13f78492ec38a4e178ddca49"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"法国生物科技公司Abivax盘前飙升35%,实验性药物最新数据提振市场信心","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4550","BK4585","BK4020","BK4579","BK4534","BK4602","ABVX","BK4553","BK4566","BK4612","BK4605","BK4535","BK4148","BK4170","BK4554","BK4581","BK4515","BK4512","BK4141","BK4588","BK4575","BK4529","BK4543","BK4532","BK4527","BK4604"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1179173462","title":"焦點股追蹤:Strategy、超微電腦、星座品牌","url":"https://stock-news.laohu8.com/highlight/detail?id=1179173462","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179173462?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 17:41","pubTimestamp":1782812476,"startTime":"0","endTime":"0","summary":"Strategy的股价在盘前交易中下跌超过3%,势将抹去昨日13%涨幅中的一部分。这家由迈克尔·塞勒执掌、以囤积比特币闻名的公司,周一宣布放弃其“永不卖出比特币”的信条,以期提振市场信心,此举引发了股价的剧烈波动。与人工智能基础设施建设相关的公司股票在盘前走高,投资者正重新涌入科技板块。超微电脑、应用材料和闪迪的股价均录得上扬。其股价小幅走高。酒精饮料巨头星座品牌将在开盘前公布季度业绩。耐克则将在收盘后发布财报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1069344957.HKD","07799","SNXX","LU1267930227.SGD","SG9999002224.SGD","LU2089985449.USD","LU0061475181.USD","BK4533","GB00BDT5M118.USD","MSTP","LU0053671581.USD","BK4516","LU0310800965.SGD","BK4170","LU2552382132.HKD","LU0348723411.USD","LU1974910355.USD","LU0889566641.SGD","LU1861220033.SGD","LU0109392836.USD","SNDK","LU0238689110.USD","LU2106854487.HKD","LU0128525689.USD","LU2552382058.USD","BK4566","BK4585","IE00BFXG1179.USD","LU2413666426.HKD","LU0011850046.USD","BK4558","BK4519","IE00BFXG0V08.USD","LU1917777945.USD","LU2413666699.HKD","MSTX","LU0097036916.USD","LU2290526834.HKD","LU1267930813.SGD","LU1815333072.USD","3LMI.UK","LU0158827781.USD","04336","LU0061474960.USD","LU1778281490.HKD","MSTW","LU0354030511.USD","APED","LU0889565833.HKD","BK4147","LU0444971666.USD","WNTR","LU0198837287.USD","LU0310800379.SGD","LU0823411888.USD","BK4169","BK4567","BK4588","BK4596","LU0868494708.USD","LU0786609619.USD","LU0942090050.USD","LU1303367103.USD","MTYY","MSTZ","LU0476273544.USD","LU0289960550.SGD","SMCX","LU1035775433.USD","LU2089283258.USD","NKE","IE00BQXX3F31.USD","09799","LU1003077747.HKD","LU0029864427.USD","LU0096364046.USD","LU2098885051.SGD","LU1267930573.SGD","LU2360107168.USD","LU0347712357.USD","LU0274383776.USD","BK4504","IE00BQXX3C00.GBP","LMI3.UK","LU2458330243.SGD","IE00B5949003.HKD","SMCC","SMCZ","LU1642822529.SGD","MSTY.UK","BK4543","07399","IE00BD6J9T35.USD","LU0708994859.HKD","LU0792757196.USD","LU2271345857.HKD","IE00BYQQ9H92.USD","LU0738911758.USD","BK4518","MSII","LU1153585028.USD","SNDU","LU1868836591.USD","LU0957808578.USD","LU1823568750.SGD","09399","LU0444973449.USD","BK4600","IE00BSNM7G36.USD","LU0081259029.USD","LU2111349929.HKD","MST","BK4023","LU0175139822.USD","LU2458330169.SGD","BK4139","SMCI","LU2023250843.SGD","LU0868494617.USD","MSDD","LU0949170772.SGD","LU1868836914.USD","BK4561","LU0054578231.USD","LU0661504455.SGD","LU2552382215.SGD","MSTR","LU2931357623.SGD","BK4534","3SMI.UK","LU1989763005.USD","LU1674673428.USD","AMAT","SG9999001424.SGD","STZ","BK4581","ABVX","LU0096362180.USD","LU1046421795.USD","LU0052756011.USD","LU0354030438.USD","IE0009356076.USD","LU1868837300.USD","SMCY","IMST","SMI3.UK","LU1803068979.SGD","MSTU","SG9999002232.USD","LU2089284900.SGD","LU0158827948.USD","LU1861215975.USD","LU0553294199.USD","LU1674673691.USD","LU2023251221.USD","LU2028103732.USD","SMCL","LU1868836757.USD","LU0079474960.USD","LU0545039389.USD","LU2023250504.SGD","BK4595","LU1721428933.USD","MSOO","MSTK","SMYY","LU0957791311.USD","LU0128525929.USD","LU0963586101.USD","LU1868837136.USD","SMST","IE00BQXX3D17.EUR","MSST","BK4559","LU1989773731.SGD","LU1815336760.USD","BK4146","MSTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123996127","title":"異動解讀|Abivax S.A.盤前上漲25.85%,三期維持試驗補充數據積極驅動股價加速反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=1123996127","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123996127?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 16:00","pubTimestamp":1782806448,"startTime":"0","endTime":"0","summary":"6月30日,Abivax S.A.盘前上涨25.85%,报120.33美元/股,成交额2.18万美元。此前50mg组曾因报告多例癌症病例致股价从130美元附近暴跌至约70美元,跌幅一度近50%。本次补充数据确认疗效并消除安全性新增隐患,前期争议逐步消化,多头情绪加速升温,股价持续回补前期跌幅。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196891450","title":"異動解讀|Abivax S.A.夜盤上漲27.93%,三期維持試驗補充數據積極加速股價反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=1196891450","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196891450?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 08:05","pubTimestamp":1782777901,"startTime":"0","endTime":"0","summary":"6月30日,Abivax S.A.夜盘上涨27.93%,报123.0美元/股,成交额1230.0美元。消息面上,公司公布ABTECT维持试验Part 2积极数据:50mg obefazimod在诱导期未应答患者中实现37.2%临床缓解率及61.5%临床应答率;维持期复发患者重新用药后应答率和缓解率分别达69.7%和45.0%,且未出现新安全信号。此前50mg组曾报告多例癌症病例致股价一度暴跌近50%,本次补充数据安全性无新增隐患,争议逐步消化叠加疗效确认,多头情绪加速升温,股价持续回补前期跌幅。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192631370","title":"異動解讀|Abivax S.A.盤後上漲21.37%,三期試驗安全性爭議持續消化中反彈動能加強","url":"https://stock-news.laohu8.com/highlight/detail?id=1192631370","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192631370?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 05:07","pubTimestamp":1782767247,"startTime":"0","endTime":"0","summary":"6月30日,Abivax S.A.盘后上涨21.37%,报116.5美元/股,成交额1448.29万美元。消息面上,公司核心药物obefazimod三期ABTECT维持试验此前因50mg组出现多例癌症病例,股价自130美元附近暴跌至约70美元,跌幅一度近50%。此后部分投资者认为癌症病例更可能与患者年龄相关,且该试验已达到主要终点,前期市场反应或过度。近期欧洲医疗保健板块领涨,Abivax在欧洲市场已率先大幅反弹,安全性争议逐步消化背景下多头情绪持续升温,股价加速回补前期跌幅。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138200670","title":"異動解讀|Abivax S.A.盤中上漲5.48%,三期試驗安全性爭議中多空博弈加劇","url":"https://stock-news.laohu8.com/highlight/detail?id=1138200670","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138200670?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 22:28","pubTimestamp":1782484132,"startTime":"0","endTime":"0","summary":"6月26日,Abivax S.A.盘中上涨5.48%,报96.91美元/股,成交额5040.65万美元。消息面上,公司核心药物obefazimod三期ABTECT维持试验此前因50mg组出现多例癌症病例,股价自130美元附近暴跌至约70美元。此后部分投资者认为癌症病例更可能与患者年龄相关,且该试验已达到主要终点,前期反应或过度。近日股价在安全性争议消化过程中持续震荡,多空分歧加剧,当前盘中出现较强反弹。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166922033","title":"異動解讀|Abivax S.A.盤後下跌5.38%,三期試驗安全性爭議持續壓制反彈動能","url":"https://stock-news.laohu8.com/highlight/detail?id=1166922033","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166922033?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 04:05","pubTimestamp":1782417909,"startTime":"0","endTime":"0","summary":"6月26日,Abivax S.A.盘后下跌5.38%,报92.37美元/股,成交额24.67万美元。消息面上,公司核心药物obefazimod三期ABTECT维持试验此前因50mg组出现多例癌症病例,股价自130美元附近暴跌至约70美元,跌幅一度近50%。此后部分投资者认为癌症病例更可能与患者年龄相关,股价一度反弹至100美元上方。但当前市场对安全性争议的分歧尚未完全消化,技术性反弹动能持续减弱,股价再度回落并延续下行趋势。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148637470","title":"異動解讀|Abivax S.A.盤中下跌5.62%,三期試驗安全性爭議持續壓制反彈動能","url":"https://stock-news.laohu8.com/highlight/detail?id=1148637470","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148637470?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 00:33","pubTimestamp":1782405206,"startTime":"0","endTime":"0","summary":"6月26日,Abivax S.A.盘中下跌5.62%,报87.205美元/股,成交额9256.07万美元。消息面上,公司核心药物obefazimod三期ABTECT维持试验此前因50mg组出现多例癌症病例,股价自130美元附近暴跌至约70美元,跌幅一度近50%。此后部分投资者认为癌症病例更可能与患者年龄相关,前期反应或过度,股价一度反弹至100美元上方。但当前市场对安全性争议的分歧尚未完全消化,技术性反弹动能持续减弱,股价再度回落并延续下行趋势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150779863","title":"異動解讀|Abivax S.A.夜盤下跌5.84%,三期試驗安全性爭議持續壓制股價反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=1150779863","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150779863?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 15:39","pubTimestamp":1782373177,"startTime":"0","endTime":"0","summary":"6月25日,Abivax S.A.夜盘下跌5.84%,报87.11美元/股,成交额33.91万美元。消息面上,公司核心药物obefazimod三期ABTECT维持试验此前因50mg组出现多例癌症病例,股价自130美元附近暴跌至约70美元,跌幅一度近50%。此后部分投资者认为癌症病例更可能与患者年龄相关,前期反应或过度,股价一度反弹至100美元上方。但当前市场对安全性争议的分歧尚未完全消化,技术性反弹动能持续减弱,股价再度回落。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154699591","title":"異動解讀|Abivax S.A.盤中下跌5.15%,三期試驗安全性爭議未消致反彈行情受阻","url":"https://stock-news.laohu8.com/highlight/detail?id=1154699591","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154699591?lang=zh_tw&edition=fundamental","pubTime":"2026-06-24 22:15","pubTimestamp":1782310523,"startTime":"0","endTime":"0","summary":"6月24日,Abivax S.A.盘中下跌5.15%,报82.65美元/股,成交额7880.38万美元。消息面上,公司核心药物obefazimod三期ABTECT维持试验此前因50mg组出现多例癌症病例,股价自130美元附近暴跌至约70美元,跌幅一度近50%。此后市场部分投资者认为癌症病例更可能与患者年龄相关,前期反应或过度,股价一度反弹至100美元上方。当前股价再度回落,显示市场对安全性争议的分歧尚未完全消化,技术性反弹动能减弱。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194191893","title":"異動解讀|Abivax S.A.盤中上漲5.15%,三期試驗安全性爭議消化後股價延續技術性反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=1194191893","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194191893?lang=zh_tw&edition=fundamental","pubTime":"2026-06-17 22:59","pubTimestamp":1781708376,"startTime":"0","endTime":"0","summary":"6月17日,Abivax S.A.盘中上涨5.15%,报102.48美元/股,成交额5767.44万美元。消息面上,公司核心药物obefazimod三期ABTECT维持试验此前因50mg组出现多例癌症病例,股价自130美元附近暴跌至约70美元,跌幅一度近50%。此后部分投资者认为癌症病例更可能与患者年龄相关,前期市场反应或过度。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":43,"code":"91000000","status":"200"}]}}